GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Pfizer Ltd

Pfizer Ltd Reports Q2 FY27 Net Profit of Rs. 313.25 crore, Revenue at Rs. 726.86 crore

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 03 Nov 2026, 02:22 PM IST  ·  BSE ID: 8a84da91-c0e2-44ba-a57e-1513f5ed4684
View Original BSE Filing (PDF)
💡
In Simple Terms
Pfizer Ltd announced its quarterly financial results, showing significantly higher profits and revenues compared to the same period last year.
🤖 AI Summary
  • Pfizer Ltd's Net Profit for Q2 FY27 was Rs. 313.25 crore, a 65.73% increase from Rs. 189.02 crore in Q2 FY26.
  • Revenue from operations in Q2 FY27 stood at Rs. 726.86 crore, up 13.16% from Rs. 642.34 crore in Q2 FY26.
  • Profit Before Tax (PBT) for Q2 FY27 reached Rs. 422.83 crore, which includes Rs. 132.06 crore in exceptional items.
  • Earnings per share (Basic and Diluted) for Q2 FY27 increased to Rs. 68.47 from Rs. 41.32 in Q2 FY26.
  • Total comprehensive income for Q2 FY27 was Rs. 312.71 crore, compared to Rs. 188.11 crore in Q2 FY26.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from operations (Q2 FY27)
726.86 crore
13.16%
Net profit for the period (Q2 FY27)
313.25 crore
65.73%
Earnings per share (Basic and Diluted) (Q2 FY27)
68.47
65.71%
Profit before tax (Q2 FY27)
422.83 crore
65.58%
Total Assets (As at 30 September 2026)
5,292.98 crore
🏢 How This Affects the Company
📈
Business Impact
The increase in revenue from operations indicates a growth in sales for Pfizer Ltd's products during the quarter. The significant exceptional item also impacts the profitability reported.
💰
Financial Impact
The company reported higher net profit and total comprehensive income, enhancing its financial performance for the quarter and half-year. The balance sheet shows an increase in total assets to Rs. 5,292.98 crore as of September 30, 2026.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, as reflected in the net profit of Rs. 313.25 crore and Earnings Per Share of Rs. 68.47 for Q2 FY27.
🔍
Management Signal
The approval of the unaudited financial results by the Board indicates management's adherence to regulatory disclosure requirements and ongoing business operations.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q3 FY27 results — monitor revenue and net profit growth trends.
Updates on exceptional items — clarify nature and recurrence of Rs. 132.06 crore amount.
Analysis of cash flow from operations — assess sustainability of cash generation.
LOW RISK The filing reports strong financial results with no new risks identified.
💡 Investor Takeaway
Pfizer Ltd reported a Q2 FY27 net profit of Rs. 313.25 crore, a 65.73% increase from Rs. 189.02 crore in Q2 FY26. Revenue from operations grew 13.16% to Rs. 726.86 crore from Rs. 642.34 crore in Q2 FY26, demonstrating improved financial performance.
⚖️ Strengths & Concerns

✅ Positives

  • Net profit for Q2 FY27 rose by 65.73% to Rs. 313.25 crore, from Rs. 189.02 crore in Q2 FY26, signaling robust profitability.
  • Revenue from operations for Q2 FY27 increased by 13.16% to Rs. 726.86 crore, compared to Rs. 642.34 crore in Q2 FY26.

⚠️ Concerns

  • Cost of materials consumed for the half-year ended September 30, 2026, was Rs. 161.53 crore, up from Rs. 158.69 crore in the prior half-year.
  • Other income for the half-year ended September 30, 2026, decreased to Rs. 92.17 crore from Rs. 109.02 crore in the prior half-year.
📅 Company Track Record
Pfizer Ltd reported Q1 FY27 net profit of Rs. 204.47 crore, with revenue at Rs. 653.17 crore. The Q2 FY27 results show sequential growth in both net profit and revenue from Q1 FY27. For the full FY26, the company's net profit was Rs. 722.43 crore and revenue from operations was Rs. 2,519.65 crore.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Pfizer Ltd's net profit for Q2 FY27?
Pfizer Ltd reported a net profit of Rs. 313.25 crore for the quarter ended September 30, 2026 (Q2 FY27).
How much was Pfizer Ltd's revenue from operations in Q2 FY27?
Revenue from operations for Pfizer Ltd in Q2 FY27 was Rs. 726.86 crore.
What were the Earnings Per Share (EPS) for Pfizer Ltd in Q2 FY27?
The Basic and Diluted Earnings Per Share (EPS) for Pfizer Ltd in Q2 FY27 were Rs. 68.47.
What was Pfizer Ltd's total income for the half-year ended 30 September 2026?
Pfizer Ltd's total income for the half-year ended September 30, 2026, was Rs. 1,472.20 crore.
What were the exceptional items reported by Pfizer Ltd in Q2 FY27?
Pfizer Ltd reported exceptional items of Rs. 132.06 crore for the quarter ended September 30, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.